Negev Capital

Negev Capital primarily target companies with medications that are at early stage of clinical development.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Negev Capital Information

Geographic Data

Negev Capital headquarters map

Address: PO Box 309

City: Grand Cayman

State: other

Zip: KY1-1104

Country: KY

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$30M

Metrics

3,481,094Website Global Rank

4,096Website Monthly Traffic

Twitter Followers

Description

Negev Capital is a psychedelic medical intervention investment fund with assets of USD$20+ million. We invest in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. We aim to support those early stage companies in need of capital that promote the thoughtful, responsible, medical use of psychedelic medication for psychiatric disorders, and who have excellent management and science teams, and solid IP.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
6/2021 NanoPsy Seed Round 0
2/2022 Mindstate Design Labs Seed 11.5M
10/2022 Psylo Seed Round 3.2M
8/2021 Beckley Psytech Series B 0
12/2022 Gilgamesh Pharmaceuticals Series B 0
9/2021 MycroDose Therapeutics Seed Round -
6/2021 Ocean Bio Pre Seed Round 0
9/2021 Delix Therapeutics Series A 0
2/2022 Mindstate Design Labs Seed Round 0
9/2021 Delix Therapeutics Series A 0
9/2021 MycroDose Therapeutics Seed Round -
8/2021 Beckley Psytech Series B 0
6/2021 NanoPsy Seed Round 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research